Synthesis and biological evaluation of N-(2-fluorophenyl)-2β-deoxyfuconojirimycin acetamide as a potent inhibitor for α-l-fucosidases
作者:Atsushi Kato、Toru Okaki、Syohei Ifuku、Kasumi Sato、Yuki Hirokami、Ren Iwaki、Akiko Kamori、Shinpei Nakagawa、Isao Adachi、Peter G. Kiria、Osamu Onomura、Daishiro Minato、Kenji Sugimoto、Yuji Matsuya、Naoki Toyooka
DOI:10.1016/j.bmc.2013.08.028
日期:2013.11
In this study we revealed that the addition of an N-phenylacetamide substituent to the C-1 position of 1-deoxyfuconojirimycin (DFJ) can lead to highly potent inhibitors of alpha-L-fucosidases. A structure-activity relationship study showed that a fluoro group on the phenyl ring greatly increased its potency and selectivity. In contrast the addition of two or three fluoro groups decreased their inhibition potency. Consequently, N-(2-fluorophenyl)-2 beta-DFJ acetamide (18j) was found to display very potent and selective inhibition of bovine kidney, rat epididymis, and human lysosome alpha-L-fucosidases, with IC50 value of 0.012, 0.044, and 0.0079 mu M respectively. It is noteworthy that our designed N-phenyL-2 beta-DFJ acetamide derivative exhibited about 18-fold stronger effects on human lysosomal alpha-L-fucosidase than original DFJ and it occupied the active-site of this enzyme. We therefore expect that this compound may find applications in new therapeutic trials against genetic deficiency disorders. (C) 2013 Elsevier Ltd. All rights reserved.